Literature DB >> 21592569

Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia.

Seisho Takeuchi1, Masahide Matsushita, Martin Zimmermann, Takayuki Ikezoe, Naoki Komatsu, Taku Seriu, Martin Schrappe, Claus R Bartram, H Phillip Koeffler.   

Abstract

Methylation profile was analyzed in ninety-five patients with childhood acute lymphoblastic leukemia (ALL). Methylation of both MGMT and p16 genes were associated with higher age (p=0.01 and p=0.03, respectively). Methylation of both p15 and SHP1 genes occurred more frequently in T-ALL than in precursor B-ALL (p=0.02 and p=0.01, respectively). In contrast, methylation of the DAPK gene was more frequent in precursor B-ALL (p=0.01). Patients with methylation of multiple genes more likely had T cell phenotype, and are classified as medium/high risk (p=0.004 and p=0.03, respectively). These results suggest that methylation status is associated with clinicopathological features in childhood ALL.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21592569      PMCID: PMC3258450          DOI: 10.1016/j.leukres.2011.04.015

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  21 in total

1.  Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor.

Authors:  Luciano Di Croce; Veronica A Raker; Massimo Corsaro; Francesco Fazi; Mirco Fanelli; Mario Faretta; Francois Fuks; Francesco Lo Coco; Tony Kouzarides; Clara Nervi; Saverio Minucci; Pier Giuseppe Pelicci
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

2.  Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroup.

Authors:  M I Gutierrez; A K Siraj; M Bhargava; U Ozbek; S Banavali; M A Chaudhary; H El Solh; K Bhatia
Journal:  Leukemia       Date:  2003-09       Impact factor: 11.528

3.  DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia.

Authors:  Lili Milani; Anders Lundmark; Anna Kiialainen; Jessica Nordlund; Trond Flaegstad; Erik Forestier; Mats Heyman; Gudmundur Jonmundsson; Jukka Kanerva; Kjeld Schmiegelow; Stefan Söderhäll; Mats G Gustafsson; Gudmar Lönnerholm; Ann-Christine Syvänen
Journal:  Blood       Date:  2009-11-25       Impact factor: 22.113

4.  Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia.

Authors:  Jose Roman-Gomez; Antonio Jimenez-Velasco; Juan A Castillejo; Xabier Agirre; Manuel Barrios; German Navarro; Francisco J Molina; Maria J Calasanz; Felipe Prosper; Anabel Heiniger; Antonio Torres
Journal:  Blood       Date:  2004-06-15       Impact factor: 22.113

5.  Aberrant methylation in promoter-associated CpG islands of multiple genes in therapy-related leukemia.

Authors:  Eisuke Uehara; Seisho Takeuchi; Taizo Tasaka; Yoshiko Matsuhashi; Yang Yang; Mitsuhiro Fujita; Takahiro Tamura; Masami Nagai; H Phillip Koeffler
Journal:  Int J Oncol       Date:  2003-09       Impact factor: 5.650

6.  Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia.

Authors:  Chise Matsushita; Yang Yang; Seisho Takeuchi; Masahide Matsushita; Jacques J M Van Dongen; Tomasz Szczepanski; Claus R Bartram; Hiromi Seo; H Phillip Koeffler; Hirokuni Taguchi
Journal:  Oncol Rep       Date:  2004-07       Impact factor: 3.906

7.  Aberrant gene promoter methylation in acute promyelocytic leukaemia: profile and prognostic significance.

Authors:  Chor S Chim; Seung Y Wong; Yok L Kwong
Journal:  Br J Haematol       Date:  2003-08       Impact factor: 6.998

8.  Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia.

Authors:  Guillermo Garcia-Manero; Sima Jeha; Jerry Daniel; Jason Williamson; Maher Albitar; Hagop M Kantarjian; Jean-Pierre J Issa
Journal:  Cancer       Date:  2003-02-01       Impact factor: 6.860

9.  RARbeta2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia.

Authors:  Letetia C Jones; Ayalew Tefferi; Gregory E Idos; Takashi Kumagai; Wolf-K Hofmann; H Phillip Koeffler
Journal:  Oncogene       Date:  2004-10-14       Impact factor: 9.867

10.  Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia.

Authors:  Shichun Zheng; Xiaomei Ma; Luoping Zhang; Laura Gunn; Martyn T Smith; Joseph L Wiemels; Kenneth Leung; Patricia A Buffler; John K Wiencke
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

View more
  17 in total

1.  DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: an Italian study.

Authors:  Maddalena Paganin; Martina Pigazzi; Silvia Bresolin; Riccardo Masetti; Franca Fagioli; Sabina Chiaretti; Giovanni Cazzaniga; Franco Locatelli; Andrea Pession; Geertruy te Kronnie; Giuseppe Basso
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

2.  DNA methylation patterns in EBV-positive and EBV-negative Hodgkin lymphomas.

Authors:  Myriam Ben Dhiab; Sonia Ziadi; Sarra Mestiri; Riadh Ben Gacem; Feryel Ksiaa; Mounir Trimeche
Journal:  Cell Oncol (Dordr)       Date:  2015-09-08       Impact factor: 6.730

Review 3.  Epigenetic roots of immunologic disease and new methods for examining chromatin regulatory pathways.

Authors:  Ian A MacDonald; Nathaniel A Hathaway
Journal:  Immunol Cell Biol       Date:  2014-12-23       Impact factor: 5.126

4.  [Promoter methylation and expression of death-associated protein kinase gene in acute leukemia].

Authors:  Wei-Hua Zhao; Fan-Yi Meng; Yong-Rong Lai; Zhi-Gang Peng; Jie Ma
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

5.  Correlations between histological characterizations and methylation statuses of tumour suppressor genes in Wilms' tumours.

Authors:  Yen-Chein Lai; Meng-Yao Lu; Wen-Chung Wang; Tai-Cheng Hou; Chen-Yun Kuo
Journal:  Int J Exp Pathol       Date:  2022-04-18       Impact factor: 2.793

Review 6.  The epigenome as a potential mediator of cancer and disease prevention in prenatal development.

Authors:  Pushpinder Kaur; Lyndsey E Shorey; Emily Ho; Roderick H Dashwood; David E Williams
Journal:  Nutr Rev       Date:  2013-05-15       Impact factor: 7.110

Review 7.  Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.

Authors:  Keith J August; Aru Narendran; Kathleen A Neville
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546

8.  Impact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia.

Authors:  C D DiNardo; V Gharibyan; H Yang; Y Wei; S Pierce; H M Kantarjian; G Garcia-Manero; M Rytting
Journal:  Am J Hematol       Date:  2013-07-23       Impact factor: 10.047

9.  Hypermethylation of p15 gene associated with an inferior poor long-term outcome in childhood acute lymphoblastic leukemia.

Authors:  Huirong Mai; Xiaolan Liu; Yixin Chen; Changgang Li; Lizhi Cao; Xiaowen Chen; Senmin Chen; Guosheng Liu; Feiqiu Wen
Journal:  J Cancer Res Clin Oncol       Date:  2016-02       Impact factor: 4.553

Review 10.  DNA methylation as a potential mediator of environmental risks in the development of childhood acute lymphoblastic leukemia.

Authors:  Jessica A Timms; Caroline L Relton; Judith Rankin; Gordon Strathdee; Jill A McKay
Journal:  Epigenomics       Date:  2016-04-01       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.